Key result
GIRK channel inhibitors SCH23390 and U50488H inhibited ADP- and low-dose thrombin-mediated platelet aggregation, indicating GIRK channels are important functional effectors of the P2Y12 receptor.
Population
Aspirin-treated and washed human platelets
Design
Preclinical
Authors
Loading...
GIRK inhibition may curb platelet aggregation; leaves open translation to human antithrombotic strategies.
GIRK channels are identified as important functional effectors of the P2Y12 receptor in human platelets, providing mechanistic insight into platelet activation.
Shankar et al. (2004) studied this question. GIRK channel inhibitors (SCH23390 and U50488H) was evaluated on Platelet aggregation and functional responses. GIRK channel inhibitors SCH23390 and U50488H inhibited ADP- and low-dose thrombin-mediated platelet aggregation, indicating GIRK channels are important functional effectors of the P2Y12 receptor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: